Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
LEGN
LEGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LEGN News
Biotech M&A Surge Resumes with Major Deals
Jun 27 2026
NASDAQ.COM
Pharmaceutical Sector Sees $65 Billion in M&A Activity in Q1 2023
Jun 27 2026
Fool
Calidi Biotherapeutics Appoints New Independent Director
Jun 24 2026
NASDAQ.COM
Stock Futures Rise Modestly; Rumble and Others Show Strong Performance
Jun 18 2026
seekingalpha
Legend Biotech Prices Public Offering of 7.7M ADSs
Jun 18 2026
seekingalpha
Legend Biotech Prices Public Offering at $29.35 per ADS
Jun 18 2026
NASDAQ.COM
Legend Biotech Prices Public Offering of ADSs
Jun 18 2026
Newsfilter
Legend Biotech Launches $225 Million Public Offering of ADS
Jun 17 2026
seekingalpha
Legend Biotech Launches $225 Million Public Offering
Jun 17 2026
Newsfilter
LB2501 Shows Significant Efficacy in B-NHL Patients
Jun 14 2026
Newsfilter
Legend Biotech's LB2501 Shows Promising Data for Lymphoma Treatment
Jun 03 2026
NASDAQ.COM
Bluejay Diagnostics Partners with Argonaut, Shares Surge 100%
Jun 03 2026
NASDAQ.COM
Promising Phase 1 Data for LB2501 CAR-T Therapy
Jun 02 2026
Newsfilter
Legend Biotech Announces Phase 1 Results for LB2102 in Lung Cancer
Jun 02 2026
NASDAQ.COM
LB2102 Shows Promising Clinical Activity in Small Cell Lung Cancer Trials
Jun 01 2026
Newsfilter
Legend Biotech Presents Preliminary Data for LB2102 at ASCO Meeting
May 21 2026
Newsfilter
Show More News